|
|
| | H-SER-PHE-SER-NLE-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-OH Basic information |
| Product Name: | H-SER-PHE-SER-NLE-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-OH | | Synonyms: | H-SER-PHE-SER-NLE-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-OH;SFS-NLE-EHFRWGKPVGKKRRPVKVYP;SER-PHE-SER-NLE-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO;[PHE2, NLE4]-ACTH (1-24);[PHE2, NLE4]-ACTH (1-24) (HUMAN);(PHE2,NLE4)-ACTH (1-24) (HUMAN, BOVINE, MOUSE, OVINE, PORCINE, RABBIT, RAT);[PHE2, NLE4] ADRENOCORTICOTROPIC HORMONE (1-24) (HUMAN);[PHE2, NLE4]-ADRENOCORTICOTROPIC HORMONE FRAGMENT 1-24 HUMAN, RAT | | CAS: | 97773-00-7 | | MF: | C137H212N40O30 | | MW: | 2899.4 | | EINECS: | | | Product Categories: | peptide;Adrenocorticotropic Hormones (ACTH);Peptides and Proteins;Peptides for Cell Biology | | Mol File: | 97773-00-7.mol |  |
| | H-SER-PHE-SER-NLE-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-OH Chemical Properties |
| density | 1.45±0.1 g/cm3(Predicted) | | storage temp. | −20°C | | Sequence | Ser-Phe-Ser-{Nle}-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
| | H-SER-PHE-SER-NLE-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-OH Usage And Synthesis |
| Uses | (Phe2,Nle4)-ACTH (1-24) (human, bovine, rat) is a fragment of the ACTH hormone. (Phe2,Nle4)-ACTH (1-24) (human, bovine, rat) can be labeled with I125 on Tyr23 to produce a radiolabeled ligand[1]. | | References | [1] M.R. Hnatowich, et al. ACTH receptors in nervous tissue. High affinity binding–sequestration of [125I][Phe2,Nle4]ACTH 1–24 in homogenates and slices from rat brain. Canadian Journal of Physiology and Pharmacology. 1989, 38-46. |
| | H-SER-PHE-SER-NLE-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-OH Preparation Products And Raw materials |
|